Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4160638
Max Phase: Preclinical
Molecular Formula: C49H58N8O5
Molecular Weight: 839.05
Molecule Type: Small molecule
Associated Items:
ID: ALA4160638
Max Phase: Preclinical
Molecular Formula: C49H58N8O5
Molecular Weight: 839.05
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCn1cc(C[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2ccccc2)NC)C(=O)N[C@@H](CC(C)C)C(N)=O)c2ccccc21
Standard InChI: InChI=1S/C49H58N8O5/c1-5-57-30-35(37-21-13-15-23-44(37)57)28-43(48(61)53-39(45(50)58)24-31(2)3)56-47(60)41(26-33-18-10-7-11-19-33)54-49(62)42(27-34-29-52-38-22-14-12-20-36(34)38)55-46(59)40(51-4)25-32-16-8-6-9-17-32/h6-23,29-31,39-43,51-52H,5,24-28H2,1-4H3,(H2,50,58)(H,53,61)(H,54,62)(H,55,59)(H,56,60)/t39-,40+,41-,42+,43+/m0/s1
Standard InChI Key: BVTULTCQCHBZMI-UBIIGGBUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 839.05 | Molecular Weight (Monoisotopic): 838.4530 | AlogP: 4.47 | #Rotatable Bonds: 21 |
Polar Surface Area: 192.24 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 7 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.94 | CX Basic pKa: 8.34 | CX LogP: 5.56 | CX LogD: 4.57 |
Aromatic Rings: 6 | Heavy Atoms: 62 | QED Weighted: 0.06 | Np Likeness Score: -0.15 |
1. Haitham Abusara O, Freeman S, Aojula HS.. (2017) Pentapeptides for the treatment of small cell lung cancer: Optimisation by Nind-alkyl modification of the tryptophan side chain., 137 [PMID:28595067] [10.1016/j.ejmech.2017.05.053] |
Source(1):